Mostrando las entradas con la etiqueta American Heart Association. Mostrar todas las entradas
Mostrando las entradas con la etiqueta American Heart Association. Mostrar todas las entradas

04 diciembre, 2013

Statins: new American guidelines for prevention of cardiovascular disease

Just change the values or target population and more people will receive more medication, is it a real  major step in the prevention of cardiovascular disease ?  Not for me, what do you think after read the new guidelines ? Are real evidences for the use statins also in primary prevention ? One billons of persons are treated today, all over the world, with this kind of drugs, and the first blockbuster drugs is Atorvastatin.........what about the evidences, and the hundreds of articles against that ? Think for yourself......

Paul M Ridker aEmail Address, Nancy R Cook a

Guidelines released on Nov 13, 2013, by the American Heart Association (AHA) and the American College of Cardiology (ACC) for the management of cholesterol are a major step in the right direction. 1 These new guidelines emphasise prevention of stroke as well as heart disease, focus appropriately on statin therapy rather than alternative unproven therapeutic agents, and recognise that more intensive treatment is superior to less intensive treatment for many patients........full text.
Statins: new American guidelines for prevention of cardiovascular disease
Paul M Ridker,Nancy R Cook
The Lancet - 30 November 2013 ( Vol. 382, Issue 9907, Pages 1762-1765 )
DOI: 10.1016/S0140-6736(13)62388-0

20 noviembre, 2012

Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

guías publicadas por la European Society of Cardiology sobre insuficiencia cardiaca.

http://t1.gstatic.com/images?q=tbn:ANd9GcQ75WW32SzjgaVgtnp-FyrLQYh84Tpx2OIHDoLDTIR5WPzA_5PPqQ

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure association (HFA) of he ESc. European Heart Journal 2012; 33: 1787-1847.

Link: http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/Guidelines-Acute%20and%20Chronic-HF-FT.pdf
Enhanced by Zemanta

12 septiembre, 2012

Taking painkillers increases death risk, second heart attacks in survivors / American Heart Association salud equitativa at CIENCIASMEDICASNEWS - 2 hours ago Taking painkillers increases death risk, second heart attacks in survivors / American Heart Association Taking painkillers increases death risk, second heart attacks in survivors


Taking painkillers increases death risk, second heart attacks in survivors / American Heart Association

salud equitativa at CIENCIASMEDICASNEWS - 2 hours ago
Taking painkillers increases death risk, second heart attacks in survivors / American Heart Association Taking painkillers increases death risk, second heart attacks in survivors September 10, 2012 *Study Highlights:* - Heart attack survivors using common painkillers such as ibuprofen face a higher long-term risk of death or second heart attack. - The higher risk persists for at least five years. *EMBARGOED UNTIL 3 pm CT/4 pm ET, Monday, September 10, 2012* DALLAS, Sept. 10, 2012 — Heart attack survivors who take common painkillers after a heart attack [image: External li... more »

08 marzo, 2012

Sexual Activity and Cardiovascular Disease


  • AHA Scientific Statement

Sexual Activity and Cardiovascular Disease

A Scientific Statement From the American Heart Association

  1. Glenn N. Levine, MD, FAHA, Chair
  2. Elaine E. Steinke, RN, PhD, FAHA;
  3. Faisal G. Bakaeen, MD
  4. Biykem Bozkurt, MD, PhD, FAHA
  5. Melvin D. Cheitlin, MD, FAHA
  6. Jamie Beth Conti, MD
  7. Elyse Foster, MD, FAHA
  8. Tiny Jaarsma, RN, PhD, FAHA
  9. Robert A. Kloner, MD, PhD
  10. Richard A. Lange, MD, MBA, FAHA;
  11. Stacy Tessler Lindau, MD
  12. Barry J. Maron, MD
  13. Debra K. Moser, DNSc, RN, FAHA;
  14. E. Magnus Ohman, MD
  15. Allen D. Seftel, MD
  16. William J. Stewart, MD on behalf of the American Heart Association Council on Clinical Cardiology Council on Cardiovascular Nursing Council on Cardiovascular Surgery and Anesthesia, and Council on Quality of Care and Outcomes Research
Key Words:

Introduction

Sexual activity is an important component of patient and partner quality of life for men and women with cardiovascular disease (CVD), including many elderly patients.1 Decreased sexual activity and function are common in patients with CVD and are often interrelated to anxiety and depression.2,3 The intent of this American Heart Association Scientific Statement is to synthesize and summarize data relevant to sexual activity and heart disease in order to provide recommendations and foster physician and other healthcare professional communication with patients about sexual activity. Recommendations in this document are based on published studies, the Princeton Consensus Panel,4,5 the 36th Bethesda Conference,610 European Society of Cardiology recommendations on physical activity and sports participation for patients with CVD,1113 practice guidelines from the American College of Cardiology/American Heart Association1416 and other organizations,17 and the multidisciplinary expertise of the writing group. The classification of recommendations in this document are based on established ACCF/AHA criteria (Table).
View this table:
Table.
Applying Classification of Recommendation and Level of Evidence

Acute Cardiovascular Effects of Sexual Activity

Numerous studies have examined the cardiovascular and neuroendocrine response to sexual arousal and intercourse, with most assessing male physiological responses during heterosexual vaginal intercourse.1824 During foreplay, systolic and diastolic systemic arterial blood pressure and heart rate increase mildly, with more modest increases occurring transiently during sexual arousal. The greatest increases occur during the 10 to 15 seconds of orgasm, with a rapid return to baseline systemic blood pressure and heart …


Enhanced by Zemanta